sRANKL/osteoprotegerin complex and biochemical markers in a cohort of male and female hemodialysis patients
- PMID: 17993768
- DOI: 10.1007/BF03350814
sRANKL/osteoprotegerin complex and biochemical markers in a cohort of male and female hemodialysis patients
Abstract
Objective: The processes involved in bone remodeling are under the control of a multitude of systemic and local factors. Receptor activator of nuclear factor-kappaB ligand (RANKL)/osteoprotegerin (OPG) complex seems to be one of the major modulators of bone remodeling. In chronic renal failure, the cytokine systems involved in the regulation of bone turnover may be influenced, and are therefore likely to contribute to the pathogenesis of renal bone disease. The aim of the present study was the evaluation of RANKL/OPG complex in concert with other biochemical parameters in hemodialysis (HD) patients and the investigation of possible correlations between the serum levels of its components and several clinical parameters of these patients.
Methods: We measured serum levels of intact PTH (iPTH), total serum RANKL (sRANKL), osteoprotegerin (OPG), alkaline phosphatase, osteocalcin (OC), and tartrate-resistant acid phosphatase (TRAP) in 104 HD patients and in 40 healthy controls.
Results: The average serum OPG level was significantly higher, whereas the average serum concentration of RANKL was nonsignificantly lower in patients on HD therapy than in age-matched healthy controls. Consequently, the mean sRANKL/OPG ratio was significantly lower in patients. Among HD patients, serum level of OPG increased significantly with aging and with a longer duration of hemodialysis. RANKL levels were inversely correlated with age nonsignificantly in the whole group of patients and significantly in the female subgroup (r=-0.322, p=0.035), whereas RANKL/OPG ratio declined significantly with age in the entire cohort of patients (r=-0.259, p=0.008). In addition, iPTH, OC, TRAP were significantly higher in female, whereas RANKL/OPG ratio was significantly higher in male than female patients.
Conclusions: Lower values of sRANKL/OPG ratio in HD patients, as well as the age and duration of HD dependent increase of serum OPG and the age-dependent decrease of sRANKL concentration especially in women cannot be explained by the elimination of renal clearance only. Alterations in sRANKL/OPG ratio might reflect a compensatory mechanism to modulate bone remodeling in these patients.
Similar articles
-
Regulatory effect of parathyroid hormone on sRANKL-osteoprotegerin in hemodialysis patients with renal bone disease.Ther Apher Dial. 2009 Feb;13(1):49-55. doi: 10.1111/j.1744-9987.2009.00653.x. Ther Apher Dial. 2009. PMID: 19379170
-
Increased bone resorption in HD patients: is it caused by elevated RANKL synthesis?Nephrol Dial Transplant. 2005 Mar;20(3):566-70. doi: 10.1093/ndt/gfh672. Epub 2005 Jan 21. Nephrol Dial Transplant. 2005. PMID: 15665031
-
Mineral-bone metabolism markers in young hemodialysis patients.Clin Biochem. 2011 Dec;44(17-18):1425-8. doi: 10.1016/j.clinbiochem.2011.08.1143. Epub 2011 Sep 12. Clin Biochem. 2011. PMID: 21933667
-
Serum Levels of OPG, RANKL, and RANKL/OPG Ratio in Patients with Ankylosing Spondylitis: A Systematic Review and Meta-analysis.Immunol Invest. 2019 Jul;48(5):490-504. doi: 10.1080/08820139.2019.1567531. Epub 2019 Jan 28. Immunol Invest. 2019. PMID: 30689477
-
The association of osteoprotegerin and RANKL with osteoporosis: a systematic review with meta-analysis.J Orthop Surg Res. 2023 Nov 7;18(1):839. doi: 10.1186/s13018-023-04179-5. J Orthop Surg Res. 2023. PMID: 37932757 Free PMC article.
Cited by
-
Serum osteoprotegerin is markedly increased and may contribute to decreased blood T cell count in hemodialysis patients.Int Urol Nephrol. 2013 Dec;45(6):1671-7. doi: 10.1007/s11255-012-0371-1. Epub 2013 Jan 8. Int Urol Nephrol. 2013. PMID: 23296793
-
Comparative study of quantitative ultrasonography and dual-energy X-ray absorptiometry for evaluating renal osteodystrophy in children with chronic kidney disease.J Bone Miner Metab. 2011 May;29(3):321-7. doi: 10.1007/s00774-010-0220-1. Epub 2010 Sep 16. J Bone Miner Metab. 2011. PMID: 20845051
-
Muscle-Bone Crosstalk in Chronic Kidney Disease: The Potential Modulatory Effects of Exercise.Calcif Tissue Int. 2021 Apr;108(4):461-475. doi: 10.1007/s00223-020-00782-4. Epub 2021 Jan 2. Calcif Tissue Int. 2021. PMID: 33388899 Review.
-
An osteoclastogenesis system, the RANKL/RANK signalling pathway, contributes to aggravated allergic inflammation.Br J Pharmacol. 2019 Jun;176(11):1664-1679. doi: 10.1111/bph.14615. Epub 2019 Apr 15. Br J Pharmacol. 2019. PMID: 30737962 Free PMC article.
-
Impact of the uremic milieu on the osteogenic potential of mesenchymal stem cells.PLoS One. 2015 Jan 30;10(1):e0116468. doi: 10.1371/journal.pone.0116468. eCollection 2015. PLoS One. 2015. PMID: 25635832 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical